CiRC Biosciences

Chicago, IL · Founded 2019 · Privately Held (backing)

Developer of cell-based therapies designed to offer treatments for serious diseases with high unmet needs, with an initial focus on blindness. CiRC Biosciences is based in Chicago, IL and was founded in 2019. Its last reported valuation was $24 million in Dec 2020. It has raised $39.1 million across 2 recorded rounds; the latest was a $7 million debt round in Apr 2024.

Last reported valuation
$24.0M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
Debt
Apr 2024
Team — not yet on record

No current team members for CiRC Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CiRC Biosciences with a free account
  • ·Watch CiRC Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View